Bridge Therapeutics

Bridge Therapeutics, Inc. is an innovative pharmaceutical company in the development stage, dedicated to the patented drug combination BT-205 (U.S. Patent #8410092) approved by the FDA and EMA for the treatment of chronic pain in patients undergoing opioid therapy.